Terms: = Gastric cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Clinical Outcome
29 results:
1. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
2. Identification of specific role of SNX family in gastric cancer prognosis evaluation.
Hu B; Yin G; Sun X
Sci Rep; 2022 Jun; 12(1):10231. PubMed ID: 35715463
[TBL] [Abstract] [Full Text] [Related]
3. HELICOBACTER PYLORI cagA VIRULENCE GENE AND SEVERE ESOGASTRODUODENAL DISEASES: IS THERE AN ASSOCIATION?
Oliveira AKS; Silva LLL; Miguel MP; Blanco AJV; Carneiro LC; Barbosa MS
Arq Gastroenterol; 2021; 58(4):468-475. PubMed ID: 34909852
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract] [Full Text] [Related]
5. A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
Liu X; Guo W; Zhang W; Yin J; Zhang J; Zhu X; Liu T; Chen Z; Wang B; Chang J; Lv F; Hong X; Wang H; Wang J; Zhao X; Wu X; Li J
BMC Cancer; 2017 Mar; 17(1):188. PubMed ID: 28288572
[TBL] [Abstract] [Full Text] [Related]
6. Association between cagA, vacAi, and dupA genes of Helicobacter pylori and gastroduodenal pathologies in Chilean patients.
Paredes-Osses E; Sáez K; Sanhueza E; Hebel S; González C; Briceño C; García Cancino A
Folia Microbiol (Praha); 2017 Sep; 62(5):437-444. PubMed ID: 28283946
[TBL] [Abstract] [Full Text] [Related]
7. clinical outcomes and Complications of Endoscopic Submucosal Dissection for Superficial gastric Neoplasms in the Elderly.
Yang TC; Hou MC; Chen PH; Hsin IF; Chen LK; Tsou MY; Lin HC; Lee FY
Medicine (Baltimore); 2015 Nov; 94(44):e1964. PubMed ID: 26554806
[TBL] [Abstract] [Full Text] [Related]
8. Self-Expandable Metallic Stent Placement in Malignant gastric Outlet Obstruction: A Comparison Between 2 Brands of Stents.
Ye BW; Lee KC; Hsieh YC; Li CP; Chao Y; Hou MC; Lin HC
Medicine (Baltimore); 2015 Jul; 94(29):e1208. PubMed ID: 26200641
[TBL] [Abstract] [Full Text] [Related]
9. Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of Western-type Helicobacter pylori strains.
Lind J; Backert S; Pfleiderer K; Berg DE; Yamaoka Y; Sticht H; Tegtmeyer N
PLoS One; 2014; 9(5):e96488. PubMed ID: 24800748
[TBL] [Abstract] [Full Text] [Related]
10. Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancer.
Sonnenblick A; Rottenberg Y; Kadouri L; Wygoda M; Rivkind A; Vainer GW; Peretz T; Hubert A
Med Oncol; 2012 Dec; 29(5):3035-8. PubMed ID: 22773040
[TBL] [Abstract] [Full Text] [Related]
11. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.
Streppel MM; Vincent A; Mukherjee R; Campbell NR; Chen SH; Konstantopoulos K; Goggins MG; Van Seuningen I; Maitra A; Montgomery EA
Hum Pathol; 2012 Oct; 43(10):1755-63. PubMed ID: 22542127
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of the clinical relevance of hrgA gene in patients with Helicobacter pylori infection.
Tanaka M; Shimoyama T; Sawaya M; Igarashi T; Yamai K; Fukuda S
Hepatogastroenterology; 2012; 59(113):304-6. PubMed ID: 22251550
[TBL] [Abstract] [Full Text] [Related]
13. Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.
Iqbal S; Goldman B; Fenoglio-Preiser CM; Lenz HJ; Zhang W; Danenberg KD; Shibata SI; Blanke CD
Ann Oncol; 2011 Dec; 22(12):2610-2615. PubMed ID: 21415234
[TBL] [Abstract] [Full Text] [Related]
14. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in gastric carcinoma].
Wu Q; Li ZS; Li DW; Peng ZH; Yang ZR
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):498-501. PubMed ID: 19742344
[TBL] [Abstract] [Full Text] [Related]
15. Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology.
Gao L; Weck MN; Michel A; Pawlita M; Brenner H
Cancer Res; 2009 Apr; 69(7):2973-80. PubMed ID: 19318564
[TBL] [Abstract] [Full Text] [Related]
16. Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma.
Chung SJ; Kim JS; Kim H; Kim SG; Kim CW; Jung HC; Song IS
J Clin Gastroenterol; 2009 Apr; 43(4):312-7. PubMed ID: 18936712
[TBL] [Abstract] [Full Text] [Related]
17. Diversity of Helicobacter pylori cagA and vacA genes in Costa Rica: its relationship with atrophic gastritis and gastric cancer.
Con SA; Takeuchi H; Valerín AL; Con-Wong R; Con-Chin GR; Con-Chin VG; Nishioka M; Mena F; Brenes F; Yasuda N; Araki K; Sugiura T
Helicobacter; 2007 Oct; 12(5):547-52. PubMed ID: 17760724
[TBL] [Abstract] [Full Text] [Related]
18. Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes.
Seno H; Satoh K; Tsuji S; Shiratsuchi T; Harada Y; Hamajima N; Sugano K; Kawano S; Chiba T
J Gastroenterol Hepatol; 2007 May; 22(5):729-37. PubMed ID: 17444864
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia.
Erzin Y; Koksal V; Altun S; Dobrucali A; Aslan M; Erdamar S; Dirican A; Kocazeybek B
Helicobacter; 2006 Dec; 11(6):574-80. PubMed ID: 17083380
[TBL] [Abstract] [Full Text] [Related]
20. Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.
Dragovich T; McCoy S; Fenoglio-Preiser CM; Wang J; Benedetti JK; Baker AF; Hackett CB; Urba SG; Zaner KS; Blanke CD; Abbruzzese JL
J Clin Oncol; 2006 Oct; 24(30):4922-7. PubMed ID: 17050876
[TBL] [Abstract] [Full Text] [Related]
[Next]
